Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2303-2310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hearing status in patients with rheumatoid arthritis

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 10, 2017-10 ,pp. : 895-899

Cambridge University Press

Access to resources Recommend Favorite

Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study

By Gibofsky Allan   Palmer William R.   Goldman John A.   Lautzenheiser Richard L.   Markenson Joseph A.   Weaver Arthur   Schiff Michael H.   Keystone Edward C.   Paulus Harold E.   Harrison Melanie J.   Whitmore James B.   Leff Jonathan A.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 169-183

Informa Healthcare

Access to resources Recommend Favorite

Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards

By Ruof Jörg   Hülsemann Jan   Mittendorf Thomas   Handelmann Silke   Aultman Rick   Schulenburg J.   Zeidler Henning   Merkesdal Sonja  

The European Journal of Health Economics, Vol. 5, Iss. 1, 2004-02 ,pp. : 64-69

Springer Publishing Company

Access to resources Recommend Favorite

Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data

By Wu Eric   Chen Lei   Birnbaum Howard   Yang Elaine   Cifaldi Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1749-1759

Informa Healthcare

Access to resources Recommend Favorite